Exclusive: Suburban Diagnostics in sale talks with Dr Lal Pathlabs, Metropolis, PharmEasy, others

Mumbai: Pathology services provider Suburban Diagnostics is in talks with Dr. Lal PathLabs, Metropolis NSE -0.77 % Healthcare, PharmEasy, and a clutch of private equity funds for a complete sale, said people close to the development.

The Mumbai-based diagnostics chain, backed by Sequoia Capital, has received bids ranging from Rs 800 crore to Rs 1,200 crore for the buyout, said two people in the know, as the industry sees high interest due to the Covid-19 pandemic.